Arrevus, Inc.
Biotechnology company · Raleigh, North Carolina, United States
Arrevus, Inc. is a biotechnology company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2015. It has received 10 US government small-business research awards (SBIR/STTR) from health agencies, $4.2 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $150,000 sold in a notice filed in 2019.
Arrevus at a glance
What does Arrevus do?
US government research funding
10 SBIR/STTR small-business research awards from US health agencies, $4.2 million in total (2018 to 2023). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute on Drug Abuse.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $150,000 sold (2019).
Frequently asked questions about Arrevus
Where is Arrevus headquartered?
Arrevus, Inc. is headquartered in Raleigh, North Carolina, United States.
What does Arrevus do?
Arrevus, Inc. is a biotechnology company.
When was Arrevus founded?
The earliest incorporation on record for Arrevus, Inc. is in 2015, according to public company registers.
Similar companies
- NuPulseCV, Inc.Raleigh, North Carolina, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.